NS 1738
NS 1738 Basic information
- Product Name:
- NS 1738
- Synonyms:
-
- NS 1738
- N-(5-Chloro-2-hydroxyphenyl)-N'-[2-chloro-5-(trifluoromethyl)phenyl]urea
- NSC 213859
- 1-(5-Chloro-2-hydroxy-phenyl)-3-(2-chloro-5-trifluoromethyl-phenyl)-urea
- Urea, N-(5-chloro-2-hydroxyphenyl)-N'-[2-chloro-5-(trifluoromethyl)phenyl]-
- NS 1738 (NSC 213859)
- NS 1738,Nicotinic acetylcholine receptors,NSC213859,inhibit,Inhibitor,nAChR,NS-1738,NSC-213859,NS1738
- NS 1738, 10 mM in DMSO
- CAS:
- 501684-93-1
- MF:
- C14H9Cl2F3N2O2
- MW:
- 365.13
- Mol File:
- 501684-93-1.mol
NS 1738 Chemical Properties
- Boiling point:
- 344.1±42.0 °C(Predicted)
- Density
- 1.617±0.06 g/cm3(Predicted)
- storage temp.
- Store at RT
- solubility
- DMSO (Slightly), Methanol (Slightly)
- form
- White crystalline solid.
- pka
- 8.08±0.13(Predicted)
- color
- Off-White to Light Grey
NS 1738 Usage And Synthesis
Description
NS 1738 is a positive allosteric modulator of the α7-containing neuronal nicotinic acetylcholine receptors (nAChRs). When applied in the presence of ACh, NS 1738 increases the peak amplitude of the current flowing through α7-containing nAChRs (EC50 = 3.4 μM). NS 1738 displays no substantial activity for α4β2-, α3β3-, and α1-containing receptors. It is modestly brain-penetrant and counteracts (-)-scopolamine-induced deficit in acquisition of a water-maze learning task in rats. NS 1738 also improves performance in the rat social recognition test. NS 1738 is used to selectively evaluate the role of α7-containing nAChRs in signaling pathways.
Uses
NS 1738 is a selective a7 nAchR allosteric modulator.
Biological Activity
Selective positive allosteric modulator of α 7 nicotinic acetylcholine receptors. Exhibits no substantial activity for α 4 β 2, α 3 β 3 and α 1-containing receptors. Displays cognitive-enhancing properties in vivo .
in vivo
To estimate the ability of NS 1738 to permeate the blood-brain barrier, rats are administered 10 mg/kg NS 1738 intraperitoneally. Peak brain concentrations are measured approximately 30 min after injection, and they amount to ~80 ng/mL (~200 nM) at this dose. The ratio between the amount of compound entering the brain and that in plasma is AUCbrain /AUCplasma=0.50. The half-life in plasma is estimated to 42 min. Incubation of NS1738 with isolated liver microsomes in vitro indicates that approximately 60 and 75% of NS 1738 is metabolized via the cytochrome P450 system in mouse and rat, respectively, within 1 h. Adult rats administered NS 1738 at 10 and 30 mg/kg i.p. immediately following the initial exposure to a juvenile rat (T1) display significant decreases in the investigative duration of a subsequent exposure to the same juvenile (T2) 2 h later (T2/T1 ratio of 0.69±0.13 and 0.61±0.07, respectively)[1].
storage
Store at RT
References
[1] DANIEL B TIMMERMANN. An allosteric modulator of the alpha7 nicotinic acetylcholine receptor possessing cognition-enhancing properties in vivo.[J]. Journal of Pharmacology and Experimental Therapeutics, 2007, 323 1: 294-307. DOI: 10.1124/jpet.107.120436
[2] QING CHENG Jerrel L Y. Presynaptic α7 nicotinic acetylcholine receptors enhance hippocampal mossy fiber glutamatergic transmission via PKA activation.[J]. Journal of Neuroscience, 2014: 124-133. DOI: 10.1523/jneurosci.2973-13.2014
[3] KELEN FREITAS M I D F Ivy Carroll. The antinociceptive effects of nicotinic receptors α7-positive allosteric modulators in murine acute and tonic pain models.[J]. Journal of Pharmacology and Experimental Therapeutics, 2013, 344 1: 264-275. DOI: 10.1124/jpet.112.197871
NS 1738Supplier
- Tel
- 821-50328103-801 18930552037
- 3bsc@sina.com
- Tel
- 888-539-0666
- info@emmx.com
- Tel
- 021-65675885 18964387627
- info@efebio.com
- Tel
- 021-61312847; 18021002903
- 3008007409@qq.com
- Tel
- 15076683720
- klq@cw-bio.com